Related Experiment Video
Updated: Jun 21, 2026

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
Published on: December 19, 2025
WITHDRAWN: Antibiotics for preventing leptospirosis.
Fábio Guidugli1, Aldemar A Castro, Alvaro N Atallah
1Brazilian Cochrane Centre, Rua Pedro de Toledo, 598, Sao Paulo, SP, Brazil, 04039-001.
Doxycycline effectively prevents leptospirosis in high-risk individuals, particularly soldiers in endemic areas. While beneficial, it carries a risk of adverse effects, necessitating careful consideration.
Area of Science:
- Infectious Diseases
- Public Health
- Preventive Medicine
Background:
- Leptospirosis is a serious animal-borne infectious disease with a significant mortality rate.
- Doxycycline is a commonly prescribed antibiotic for leptospirosis prophylaxis in clinical settings.
Purpose of the Study:
- To assess the efficacy and safety of antibiotic regimens for leptospirosis prophylaxis.
- To compare antibiotic prophylaxis against placebo or other antibiotic treatments.
Main Methods:
- Systematic review of randomized clinical trials evaluating antibiotic prophylaxis for leptospirosis.
- Searches across multiple databases (EMBASE, LILACS, MEDLINE, etc.) with no date or language restrictions.
- Independent data extraction and quality assessment of included trials.
Main Results:
- Two trials met inclusion criteria, comparing doxycycline with placebo in 1022 participants (primarily soldiers).
- Doxycycline significantly reduced symptomatic leptospirosis (0.6% vs. 4.9%, NNT=24).
- Adverse effects were slightly higher with doxycycline (3% vs. 0.2%, NNH=39).
Conclusions:
- Doxycycline prophylaxis is effective in preventing leptospirosis among soldiers in high-risk endemic areas.
- The generalizability of these findings to other populations requires further investigation.
Related Concept Videos
Bacterial Phylum Spirochaetes
Acute Pyelonephritis II: Diagnostic Studies and Management
Antiprotozoal Agents
Rocky Mountain Spotted Fever
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis

